199 related articles for article (PubMed ID: 15514091)
1. Latex immunoturbidimetric assay for soluble fibrin complex.
Hamano A; Umeda M; Ueno Y; Tanaka S; Mimuro J; Sakata Y
Clin Chem; 2005 Jan; 51(1):183-8. PubMed ID: 15514091
[TBL] [Abstract][Full Text] [Related]
2. Measurement of soluble fibrin monomer-fibrinogen complex in plasmas derived from patients with various underlying clinical situations.
Nakahara K; Kazahaya Y; Shintani Y; Yamazumi K; Eguchi Y; Koga S; Wada H; Matsuda M
Thromb Haemost; 2003 May; 89(5):832-6. PubMed ID: 12719780
[TBL] [Abstract][Full Text] [Related]
3. A novel monoclonal antibody to fibrin monomer and soluble fibrin for the detection of soluble fibrin in plasma.
Hamano A; Tanaka S; Takeda Y; Umeda M; Sakata Y
Clin Chim Acta; 2002 Apr; 318(1-2):25-32. PubMed ID: 11880109
[TBL] [Abstract][Full Text] [Related]
4. Measurement of plasma fibrin D-dimer levels with the use of a monoclonal antibody coupled to latex beads.
Greenberg CS; Devine DV; McCrae KM
Am J Clin Pathol; 1987 Jan; 87(1):94-100. PubMed ID: 3541576
[TBL] [Abstract][Full Text] [Related]
5. Determination of plasma soluble fibrin using a new ELISA method in patients with disseminated intravascular coagulation.
Okajima K; Uchiba M; Murakami K; Okabe H; Takatsuki K
Am J Hematol; 1996 Mar; 51(3):186-91. PubMed ID: 8619398
[TBL] [Abstract][Full Text] [Related]
6. Rapid detection of cross-linked fibrin degradation products in plasma using monoclonal antibody-coated latex particles.
Elms MJ; Bunce IH; Bundesen PG; Rylatt DB; Webber AJ; Masci PP; Whitaker AN
Am J Clin Pathol; 1986 Mar; 85(3):360-4. PubMed ID: 2875646
[TBL] [Abstract][Full Text] [Related]
7. The monoclonal antibody that recognizes an epitope in the C-terminal region of the fibrinogen alpha-chain reacts with soluble fibrin and fibrin monomer generated by thrombin but not with those formed as plasmin degradation products.
Suzuki A; Ebinuma H; Matsuo M; Miyazaki O; Yago H
Thromb Res; 2007; 121(3):377-85. PubMed ID: 17561232
[TBL] [Abstract][Full Text] [Related]
8. A new immunoassay for soluble fibrin enables a more sensitive detection of the activation state of blood coagulation in vivo.
Lill H; Spannagl M; Trauner A; Schramm W; Schuller D; Ofenloch-Haehnle B; Draeger B; Naser W; Dessauer A
Blood Coagul Fibrinolysis; 1993 Feb; 4(1):97-102. PubMed ID: 8457660
[TBL] [Abstract][Full Text] [Related]
9. A quantitative automated immunoassay for fibrinogen/fibrin degradation products.
Schifreen RS; Cembrowski GS; Campbell DC; Craig AR; Demyanovich ND; Jurga-Hall PA; Reider MC; Schwartz MW; Tuhy PM; Waller SJ
Clin Chem; 1985 Sep; 31(9):1468-73. PubMed ID: 4028396
[TBL] [Abstract][Full Text] [Related]
10. [Soluble fibrin is not excreted in urine and its plasma level is elevated in nephrotic syndrome].
Morikawa T; Yamashiro Y; Okano K; Kasamatsu M; Sugai H; Kitamura H; Ohba I; Hotta O; Taguma Y; Sakurai J; Kitamoto Y
Rinsho Byori; 2009 Apr; 57(4):319-23. PubMed ID: 19489432
[TBL] [Abstract][Full Text] [Related]
11. A monoclonal antibody that recognizes a neo-antigen exposed in the E domain of fibrin monomer complexed with fibrinogen or its derivatives: its application to the measurement of soluble fibrin in plasma.
Soe G; Kohno I; Inuzuka K; Itoh Y; Matsuda M
Blood; 1996 Sep; 88(6):2109-17. PubMed ID: 8822930
[TBL] [Abstract][Full Text] [Related]
12. The detection of fibrinogen-fibrin degradation products by means of a new antibody-coated latex particle.
Garvey MB; Black JM
J Clin Pathol; 1972 Aug; 25(8):680-2. PubMed ID: 5076802
[TBL] [Abstract][Full Text] [Related]
13. New enzyme immunoassay of fibrin-fibrinogen degradation products in plasma using a monoclonal antibody.
Koopman J; Haverkate F; Koppert P; Nieuwenhuizen W; Brommer EJ; Van der Werf WG
J Lab Clin Med; 1987 Jan; 109(1):75-84. PubMed ID: 3540164
[TBL] [Abstract][Full Text] [Related]
14. Higher prognostic value of soluble fibrin complexes than D-dimer and fibrin degradation product for disseminated intravascular coagulation in patients with liver cirrhosis.
Kim SY; Kim JE; Kim HK; Kim I; Yoon SS; Park S
Blood Coagul Fibrinolysis; 2013 Mar; 24(2):150-6. PubMed ID: 23314386
[TBL] [Abstract][Full Text] [Related]
15. A latex immunoassay of fibrin/fibrinogen degradation products in plasma using a monoclonal antibody.
Mirshahi M; Soria J; Soria C; Perrot JY; Boucheix C
Thromb Res; 1986 Dec; 44(6):715-28. PubMed ID: 3798417
[TBL] [Abstract][Full Text] [Related]
16. Binding of a new monoclonal antibody against N-terminal heptapeptide of fibrin alpha-chain to fibrin polymerization site 'A': effects of fibrinogen and fibrinogen derivatives, and pretreatment of samples with NaSCN.
Dempfle CE; Dollman M; Lill H; Puzzovio D; Dessauer A; Heene DL
Blood Coagul Fibrinolysis; 1993 Feb; 4(1):79-86. PubMed ID: 8457657
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibody-based plasma assays for fibrin(ogen) and derivatives, and their clinical relevance.
Kroneman H; Nieuwenhuizen W; Knot EA
Blood Coagul Fibrinolysis; 1990; 1(1):91-111. PubMed ID: 2102791
[TBL] [Abstract][Full Text] [Related]
18. Measurement of cross linked fibrin derivatives in plasma: an immunoassay using monoclonal antibodies.
Whitaker AN; Elms MJ; Masci PP; Bundesen PG; Rylatt DB; Webber AJ; Bunce IH
J Clin Pathol; 1984 Aug; 37(8):882-7. PubMed ID: 6206097
[TBL] [Abstract][Full Text] [Related]
19. Rapid quantitative evaluation of plasma D-dimer levels in thrombotic states using an automated latex photometric immunoassay.
Kario K; Matsuo T; Kabayashi H; Matsuo M; Yamamoto K; Sakurai G; Baba M
Thromb Res; 1992 May; 66(2-3):179-89. PubMed ID: 1412191
[TBL] [Abstract][Full Text] [Related]
20. Validation, calibration, and specificity of quantitative D-dimer assays.
Dempfle CE
Semin Vasc Med; 2005 Nov; 5(4):315-20. PubMed ID: 16302152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]